Dimensional Fund Advisors
SPRB

Dimensional Fund Advisors’s Spruce Biosciences SPRB Stock Holding History

Dimensional Fund Advisors’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-622
Closed -$36.7K – 3420
2024
Q1 		$36.7K Buy
+622
New +$158K ﹤0.01% 3345
2023
Q4 		– Sell
-433
Closed -$73.3K – 3464
2023
Q3 		$73.3K Hold
433
– – ﹤0.01% 3349
2023
Q2 		$69.7K Sell
433
-89
-17% -$14.9K ﹤0.01% 3375
2023
Q1 		$86.6K Buy
522
+385
+281% +$71.5K ﹤0.01% 3323
2022
Q4 		$11 Sell
137
-20
-13% -$1.67K ﹤0.01% 3482
2022
Q3 		$16K Buy
+157
New +$21.9K ﹤0.01% 3471

Other funds holding SPRB

RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return

Dimensional Fund Advisors's SPRB Position: Q2 2024 in Review

Dimensional Fund Advisors sold out of Spruce Biosciences (SPRB) in Q2 2024, closing a stake of 622 shares — an estimated $36.7K sold.

Dimensional Fund Advisors first reported a position in SPRB in Q3 2022 and held it in 6 quarters. The position peaked at $86.6K in Q1 2023. 37 funds tracked by Wall St. Rank hold SPRB as of Q2 2024.

  • Dimensional Fund Advisors reported no remaining Spruce Biosciences position as of Q2 2024 after selling out during the quarter.
  • Dimensional Fund Advisors sold 622 Spruce Biosciences shares in Q2 2024, an estimated $36.7K.
  • Dimensional Fund Advisors first reported a position in Spruce Biosciences in Q3 2022 and held it in 6 quarters.
  • Dimensional Fund Advisors's Spruce Biosciences position peaked at $86.6K in Q1 2023.
  • 37 funds tracked by Wall St. Rank held Spruce Biosciences as of Q2 2024.

Based on Dimensional Fund Advisors's 13F filing for Q2 2024, filed 9 Aug 2024.